Cancer in mice: Effects of prednisolone or mepacrine alone and with cytotoxic drugs

6Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

WHT/Ht mice were transplanted s.c. with NC carcinoma, and the tumours were excised after 2 weeks. The mice were treated orally throughout the experiments with prednisolone 500 μg kg-1 or mepacrine 3.6 μg kg-1, starting the day after tumour transplantation or, with prednisolone, the day after tumour excision. In some experiments the mice were also treated with the cytotoxic drugs methotrexate 2 mg kg-1and melphalan 1.4 mg kg-1. The excised tumours were weighed; some of them, and samples of serum, were extracted for prostanoids which were measured by radioimmunoassay. The chemotherapy lengthened the survival of the mice, but prednisolone or mepacrine had little or no effect on survival, metastasis, the response to chemotherapy, tumour size or the formation of tumour prostanoids. © The Macmillan Press Ltd., 1987.

Cite

CITATION STYLE

APA

Bennett, A., Melhuish, P. B., Patel, S., Randles, H., & Stamford, I. F. (1987). Cancer in mice: Effects of prednisolone or mepacrine alone and with cytotoxic drugs. British Journal of Cancer, 55(4), 385–388. https://doi.org/10.1038/bjc.1987.77

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free